drugset / Trial / NCT00818181

Open Label Safety Study of a Birch Pollen Allergen Extract

NCT00818181 ↗

Phase 2 Completed 73 enrolled Allergopharma GmbH & Co. KG
NaSingle-groupOpen-labelTreatment

Summary

This trial is performed to assess safety of a sublingual birch pollen extract.

Timeline

Start
2008-06
Primary completion
2009-02
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject AL0206st Other / unclassified — Other

Indications